Calithera Biosciences Inc. (CALA) announced Monday morning that it has entered into a global collaboration and license agreement with Incyte Corp. (INCY) to develop and commercialize CB-1158.
from RTT - Before the Bell http://ift.tt/2jPAYEW
via IFTTT
No comments:
Post a Comment